Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Cross-contamination

Traces of another drug - most often penicillin - got into the product from shared equipment or facilities. Even trace penicillin can trigger a severe allergic reaction in someone who was never meant to receive it.

782 FDA drug recalls with this cause, newest first.

Cross-contamination means a product picked up traces of a different drug during manufacturing, repackaging or handling - usually because equipment or a facility was shared. Penicillin is the classic case: it is a potent allergen, so FDA requires it to be made in fully separate facilities, and a single lapse can put every product that passed through the same line on the recall list. Most of these recalls are precautionary sweeps of everything a firm handled during the affected period, which is why one event can add hundreds of entries at once.

Class II · Moderate risk

Anastrozole Tablets

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

Terminated Cross-contamination American Health Packaging NDC 68001-155-04 D-1467-2019
Class II · Moderate risk

Anastrozole Tablets

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

Terminated Cross-contamination American Health Packaging NDC 60687-112-21 D-1394-2019
Class II · Moderate risk

MethylPREDNISolone Tablets

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Terminated Cross-contamination Zydus Pharmaceuticals USA Inc NDC 68382-917-11 D-1453-2019
Class II · Moderate risk

MethylPREDNISolone Tablets

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Terminated Cross-contamination Zydus Pharmaceuticals USA Inc NDC 68382-919-11 D-1451-2019
Class II · Moderate risk

MethylPREDNISolone Tablets

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Terminated Cross-contamination Zydus Pharmaceuticals USA Inc NDC 68382-918-18 D-1450-2019
Class II · Moderate risk

MethylPREDNISolone Tablets

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Terminated Cross-contamination Zydus Pharmaceuticals USA Inc NDC 68382-916-34 D-1449-2019
Class II · Moderate risk

MethylPREDNISolone Tablets

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Terminated Cross-contamination Zydus Pharmaceuticals USA Inc NDC 68382-916-01 D-1448-2019
Class II · Moderate risk

Anastrozole Tablets

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Terminated Cross-contamination Zydus Pharmaceuticals USA Inc NDC 68382-209-10 D-1441-2019
Class II · Moderate risk

ANASTROZOLE Tablets

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Terminated Cross-contamination Zydus Pharmaceuticals USA Inc NDC 68382-209-06 D-1440-2019
Class III · Low risk

Nitrofurantoin Capsules USP

Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that "These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation."

Terminated Cross-contamination American Health Packaging NDC 68084-446-01 D-0273-2019